BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 14730504)

  • 21. Two-site immunoradiometric intact parathyroid hormone assay versus C-terminal parathyroid hormone in predicting osteodystrophic bone lesions in predialysis chronic renal failure.
    Coen G; Mazzaferro S; Ballanti P; Bonucci E; Cinotti GA; Fondi G; Manni M; Pasquali M; Perruzza I; Sardella D
    J Lab Clin Med; 1993 Jul; 122(1):103-9. PubMed ID: 8320484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical Governance Issue of Parathyroid Hormone Assays and its Selection in the Management of Chronic Kidney Disease Mineral and Bone Disorders.
    Kakuta T; Ishida M; Fukagawa M
    Ther Apher Dial; 2018 Jun; 22(3):220-228. PubMed ID: 29781225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of protein kinase C activity in cells expressing human parathyroid hormone receptors by C- and N-terminally truncated fragments of parathyroid hormone 1-34.
    Whitfield JF; Isaacs RJ; Chakravarthy B; Maclean S; Morley P; Willick G; Divieti P; Bringhurst FR
    J Bone Miner Res; 2001 Mar; 16(3):441-7. PubMed ID: 11277261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of parathyroid hormone.
    Endres DB; Villanueva R; Sharp CF; Singer FR
    Endocrinol Metab Clin North Am; 1989 Sep; 18(3):611-29. PubMed ID: 2673765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The evolution of assays for parathyroid hormone.
    Martin KJ; González EA
    Curr Opin Nephrol Hypertens; 2001 Sep; 10(5):569-74. PubMed ID: 11496048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zinc nutritional status modifies renal osteodystrophy in uremic rats.
    Kimmel PL; Langman CB; Bognar B; Faugere MC; Chawla LS; Watkins DW; Malluche HH
    Clin Nephrol; 2001 Dec; 56(6):445-58. PubMed ID: 11770796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Practical considerations in PTH testing.
    Souberbielle JC; Friedlander G; Cormier C
    Clin Chim Acta; 2006 Apr; 366(1-2):81-9. PubMed ID: 16310759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The evolution of assays for parathyroid hormone.
    Goodman WG
    Semin Dial; 2005; 18(4):296-301. PubMed ID: 16076352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of the parathyroid glands on bone metabolism.
    Malluche HH; Koszewski N; Monier-Faugere MC; Williams JP; Mawad H
    Eur J Clin Invest; 2006 Aug; 36 Suppl 2():23-33. PubMed ID: 16884395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The extracellular amino-terminal region of the parathyroid hormone (PTH)/PTH-related peptide receptor determines the binding affinity for carboxyl-terminal fragments of PTH-(1-34).
    Jüppner H; Schipani E; Bringhurst FR; McClure I; Keutmann HT; Potts JT; Kronenberg HM; Abou-Samra AB; Segre GV; Gardella TJ
    Endocrinology; 1994 Feb; 134(2):879-84. PubMed ID: 8299582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The metabolic mode of circulating parathyroid hormone].
    Horiuchi T; Kinouchi T
    Nihon Rinsho; 1995 Apr; 53(4):828-34. PubMed ID: 7752468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The PTH/PTHrP receptor: biological implications].
    Ureña P
    Nefrologia; 2003; 23 Suppl 2():12-7. PubMed ID: 12778847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carboxyl-terminal parathyroid hormone fragments: role in parathyroid hormone physiopathology.
    D'Amour P; Brossard JH
    Curr Opin Nephrol Hypertens; 2005 Jul; 14(4):330-6. PubMed ID: 15931000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parathyroid hormone assay: problems and opportunities.
    Martin KJ; González EA
    Pediatr Nephrol; 2007 Oct; 22(10):1651-4. PubMed ID: 17574479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The need for reliable serum parathyroid hormone measurements.
    Torres PU
    Kidney Int; 2006 Jul; 70(2):240-3. PubMed ID: 16838038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parathyroid hormone assays--evolution and revolutions in the care of dialysis patients.
    Malluche HH; Mawad H; Trueba D; Monier-Faugere MC
    Clin Nephrol; 2003 May; 59(5):313-8. PubMed ID: 12779091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The parathyroid polyhormone hypothesis revisited.
    Nemeth EF
    Kidney Int Suppl; 2006 Jul; (102):S22-8. PubMed ID: 16810306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Intact PTH and Bio-Intact PTH Assays Among Non-Dialysis Dependent Chronic Kidney Disease Patients.
    Einbinder Y; Benchetrit S; Golan E; Zitman-Gal T
    Ann Lab Med; 2017 Sep; 37(5):381-387. PubMed ID: 28643486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selected reaction monitoring-mass spectrometric immunoassay responsive to parathyroid hormone and related variants.
    Lopez MF; Rezai T; Sarracino DA; Prakash A; Krastins B; Athanas M; Singh RJ; Barnidge DR; Oran P; Borges C; Nelson RW
    Clin Chem; 2010 Feb; 56(2):281-90. PubMed ID: 20022981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New lessons from old assays: parathyroid hormone (PTH), its receptors, and the potential biological relevance of PTH fragments.
    Goodman WG; Salusky IB; Jüppner H
    Nephrol Dial Transplant; 2002 Oct; 17(10):1731-6. PubMed ID: 12270977
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.